| Aug 14 |
CorMedix Inc. (CRMD) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
CorMedix GAAP EPS of -$0.25 in-line, revenue of $0.81M misses by $0.86M
|
| Aug 14 |
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
|
| Aug 13 |
CorMedix Q2 2024 Earnings Preview
|
| Aug 7 |
CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024
|
| Jul 31 |
These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
|
| Jul 3 |
CorMedix Inc. Announces Outpatient Availability of DefenCath
|
| Jun 18 |
CorMedix to start DefenCath label expansion program this year
|
| Jun 18 |
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
|
| May 28 |
CorMedix announces commercial agreement with dialysis provider
|
